Mumbai's luxury real estate market continues to thrive, with Blue Jet Healthcare's promoter family making a significant investment by acquiring three premium apartments in Worli for ₹202 crore. This trend highlights the growing influence of pharmaceutical sector wealth in the city's premium property segment.
Luxury Real EstateMumbaiPharmaceutical SectorHighnetworth IndividualsWorliReal EstateAug 10, 2025

The total value of the apartments acquired by Blue Jet Healthcare's promoter family in Worli is ₹202 crore.
Akshay Bansarilal Arora, promoter of Blue Jet Healthcare, purchased two units in the Palais Royale development in Worli.
Shiven Akshay Arora paid ₹88 crore for the apartment at Raheja Artesia in Worli.
Worli is becoming a notable micro-market for luxury residential developments due to its central location, improved infrastructure connectivity, and the presence of high-end residential projects offering modern amenities and superior construction quality.
The trend observed is an increasing investment of pharmaceutical sector wealth in Mumbai’s luxury housing sector, driven by the sector's growth in revenue and market capitalization during the COVID-19 pandemic. High-net-worth individuals view these properties as secure investments and status symbols.

As Mumbai continues to grow

Mumbai's prime residential prices surge 11.5% year-on-year, ranking third globally, as India's economic growth drives demand in luxury housing market.

The latest data from JLL India reveals a 21% decline in affordable housing supply below Rs 50 lakh, while premium projects saw a significant surge in demand.

Priyanka Chopra Jonas is a keen investor in the real estate space, owning multiple properties in India and the US. Here's a look at her recent transactions.

Uber has partnered with Heads Up for Tails to offer pet-friendly rides in Delhi and Mumbai, making travel more convenient and comfortable for pet owners.

A real estate investment trust (REIT) backed by asset manager Blackstone Group and Bengaluru developer Sattva Group has filed its draft papers with the Securities and Exchange Board of India (SEBI) for a ₹7000 crore initial public offering (IPO).